Arthritis drug can help treat Covid patients, trial suggests – The Times

A drug used for rheumatoid arthritis can be effective in treating patients with Covid-19 in intensive care, early trial results suggest.
Tocilizumab suppresses the immune system and reduces inflammation. The early findings are yet to be published in a peer-reviewed journal but the government has welcomed the fantastic news.
Professor Anthony Gordon, chairman in anaesthesia and critical care at Imperial College London, said: These early findings show that treatment with this immune-modulating drug…

Click here to view the original article.